Skip to main content

Jacobson Mark L.'s Form 4 filing

Axsome Therapeutics, Inc. (AXSM) · filed May 28, 2025

Accession no.
0000950170-25-078552
Filed
May 28, 2025
Trade date
May 27-28, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.23M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jacobson Mark L.CIK 0001805812Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 27, 2025Common StockMOption exerciseAcquired+20,673$6.47+$133,754.3126,456Direct
May 27, 2025Common StockSSaleDisposed−20,673$104.66−$2,163,636.185,783Direct
May 28, 2025Common StockMOption exerciseAcquired+20,000$6.47+$129,40025,783Direct
May 28, 2025Common StockSSaleDisposed−20,000$103.45−$2,069,0005,783Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 27, 2025Common StockMOption exerciseDisposed−20,673$0.00$00Direct
May 28, 2025Common StockMOption exerciseDisposed−20,000$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)